Epidemiology and Multidrug Resistance of Pseudomonas aeruginosa and Acinetobacter baumanni Isolated from Clinical Samples in Ethiopia

References

• Gupta V, Datta P, Chander J. Prevalence of metallo-beta lactamase (MBL) producing Pseudomonas spp. and Acinetobacter spp. in a tertiary care hospital in India. J Infect. 2006;52(5):311–314. doi:10.1016/j.jinf.2005.08.013
   PubMed Web of Science ®Google Scholar
• Banerjee T, Mishra A, Das A, Sharma S, Barman H, Yadav G. High prevalence and endemicity of multidrug resistant Acinetobacter spp. in intensive care unit of a tertiary care hospital, Varanasi, India. J Pathog. 2018;2018:9129083. doi:10.1155/2018/9129083
   PubMed Web of Science ®Google Scholar
• De Francesco MA, Ravizzola G, Peroni L, Bonfanti C, Manca N. Prevalence of multidrug-resistant Acinetobacter baumannii and Pseudomonas aeruginosa in an Italian hospital. J Infect Public Health. 2013;6(3):179–185. doi:10.1016/j.jiph.2012.11.006
   PubMed Web of Science ®Google Scholar
• Kaur A, Singh S. Prevalence of Extended Spectrum Betalactamase (ESBL) and Metallobetalactamase (MBL) producing Pseudomonas aeruginosa and Acinetobacter baumannii isolated from various clinical samples. J Pathog. 2018;2018:6845985. doi:10.1155/2018/6845985
   PubMed Web of Science ®Google Scholar
• Loivukene K, Sepp E, Adamson V, et al. Prevalence and antibiotic susceptibility of Acinetobacter baumannii, Pseudomonas aeruginosa and Klebsiella pneumoniae in Estonian intensive care units in comparison with European data. Scand J Infect Dis. 2006;38(11–12):1001–1008. doi:10.1080/00365540600786507
   PubMed Web of Science ®Google Scholar
• Mirzaei B, Bazgir ZN, Goli HR, Iranpour F, Mohammadi F, Babaei R. Prevalence of multi-drug resistant (MDR) and extensively drug-resistant (XDR) phenotypes of Pseudomonas aeruginosa and Acinetobacter baumannii isolated in clinical samples from Northeast of Iran. BMC Res Notes. 2020;13(1):380. doi:10.1186/s13104-020-05224-w
   PubMedGoogle Scholar
• Mohd Rani F, Ismail S, Abdullah FH, et al. Prevalence and antimicrobial susceptibilities of Acinetobacter baumannii and non-baumannii Acinetobacters from Terengganu, Malaysia and their carriage of carbapenemase genes. J Med Microbiol. 2018;67(11):1538–1543. doi:10.1099/jmm.0.000844
   PubMed Web of Science ®Google Scholar
• Mohd Sazlly Lim S, Zainal Abidin A, Liew SM, Roberts JA, Sime FB. The global prevalence of multidrug-resistance among Acinetobacter baumannii causing hospital-acquired and ventilator-associated pneumonia and its associated mortality: a systematic review and meta-analysis. J Infect. 2019;79(6):593–600. doi:10.1016/j.jinf.2019.09.012
   PubMed Web of Science ®Google Scholar
• Monnheimer M, Cooper P, Amegbletor HK, et al. High prevalence of carbapenemase-producing Acinetobacter baumannii in wound infections, Ghana, 2017/2018. Microorganisms. 2021;9(3):537. doi:10.3390/microorganisms9030537
   PubMed Web of Science ®Google Scholar
• Nasiri MJ, Zamani S, Fardsanei F, et al. Prevalence and mechanisms of carbapenem resistance in Acinetobacter baumannii: a comprehensive systematic review of cross-sectional studies from Iran. Microb Drug Resist. 2020;26(3):270–283. doi:10.1089/mdr.2018.0435
   PubMed Web of Science ®Google Scholar
• Ababneh Q, Abu Laila S, Jaradat Z. Prevalence, genetic diversity, antibiotic resistance and biofilm formation of Acinetobacter baumannii isolated from urban environments. J Appl Microbiol. 2022;133(6):3617–3633. doi:10.1111/jam.15795
   PubMed Web of Science ®Google Scholar
• Tilahun M, Gedefie A, Bisetegn H, Debash H. Emergence of high prevalence of extended-spectrum beta-lactamase and carbapenemase producing Acinetobacter species and pseudomonas aeruginosa among hospitalized patients at Dessie comprehensive specialized Hospital, North-East Ethiopia. Infect Drug Resist. 2022;15:895–911. doi:10.2147/IDR.S358116
   PubMed Web of Science ®Google Scholar
• Benmahmod AB, Said HS, Ibrahim RH. Prevalence and mechanisms of carbapenem resistance among Acinetobacter baumannii clinical isolates in Egypt. Microb Drug Resist. 2019;25(4):480–488. doi:10.1089/mdr.2018.0141
   PubMed Web of Science ®Google Scholar
• De AS, Kumar SH, Baveja SM. Prevalence of metallo-beta-lactamase producing Pseudomonas aeruginosa and Acinetobacter species in intensive care areas in a tertiary care hospital. Indian J Crit Care Med. 2010;14(4):217–219. doi:10.4103/0972-5229.76089
   PubMedGoogle Scholar
• Gildas Comlan Zohoun A, Moket D, El Hamzaoui S. Résistance à l’imipénème par production de métallo-β-lactamases par Acinetobacter baumannii et Pseudomonas aeruginosa à l’Hôpital militaire d’instruction Mohammed V de Rabat [Prevalence of Acinetobacter baumannii and Pseudomonas aeruginosa isolates resistant to imipenem by production of metallo-beta-lactamases in Rabat Military teaching hospital Mohammed V]. Ann Biol Clin. 2013;71(1):27–30. French doi:10.1684/abc.2012.0778.
   PubMedGoogle Scholar
• CLSI. Performance Standards for Antimicrobial Susceptibility Testing. CLSI Supplement M100. Wayne, PA: Clinical and Laboratory Standards Institute; 2017.
   Google Scholar
• Al-Tawfiq JA, Mohandhas TX. Prevalence of antimicrobial resistance in Acinetobacter calcoaceticus-baumannii complex in a Saudi Arabian hospital. Infect Control Hosp Epidemiol. 2007;28(7):870–872. doi:10.1086/518842
   PubMed Web of Science ®Google Scholar
• Cai B, Echols R, Magee G, et al. Prevalence of carbapenem-resistant gram-negative infections in the United States Predominated by Acinetobacter baumannii and Pseudomonas aeruginosa. Open Forum Infect Dis. 2017;4(3):ofx176. doi:10.1093/ofid/ofx176
   PubMedGoogle Scholar
• Fazeli H, Rad TM, Esfahani BN, Pourdad A, Akbari M. Risk factors and prevalence of high resistant Acinetobacter spp among hospitalized patients. J Res Med Sci. 2014;19(5):480–481.
   PubMed Web of Science ®Google Scholar
• Yayan J, Ghebremedhin B, Rasche K. Antibiotic resistance of pseudomonas aeruginosa in pneumonia at a Single University Hospital Center in Germany over a 10-Year Period. PLoS One. 2015;10(10):e0139836. doi:10.1371/journal.pone.0139836
   PubMed Web of Science ®Google Scholar
• Dehkordi SMH, Anvar SA, Rahimi E, Ahari H, Ataee M. Molecular investigation of prevalence, phenotypic and genotypic diversity, antibiotic resistance, frequency of virulence genes and genome sequencing in Pseudomonas aeruginosa strains isolated from lobster. Int J Food Microbiol. 2022;382:109901. doi:10.1016/j.ijfoodmicro.2022.109901
   PubMed Web of Science ®Google Scholar
• Garza-Gonzalez E, Llaca-Diaz JM, Bosques-Padilla FJ, Gonzalez GM. Prevalence of multidrug-resistant bacteria at a tertiary-care teaching hospital in Mexico: special focus on Acinetobacter baumannii. Chemotherapy. 2010;56(4):275–279. doi:10.1159/000319903
   PubMed Web of Science ®Google Scholar
• Al-Agamy MH, Shibl AM, Tawfik AF, Radwan HH. High prevalence of metallo-beta-lactamase-producing Pseudomonas aeruginosa from Saudi Arabia. J Chemother. 2009;21(4):461–462. doi:10.1179/joc.2009.21.4.461
   PubMed Web of Science ®Google Scholar
• Aljindan R, Bukharie H, Alomar A, Abdalhamid B. Prevalence of digestive tract colonization of carbapenem-resistant Acinetobacter baumannii in hospitals in Saudi Arabia. J Med Microbiol. 2015;64(Pt 4):400–406. doi:10.1099/jmm.0.000033
   PubMedGoogle Scholar
• Addis T, Araya S, Desta K. Occurrence of multiple, extensive and pan drug-resistant Pseudomonas Aeruginosa and Carbapenemase production from presumptive isolates stored in a biobank at Ethiopian public health institute. Infect Drug Resist. 2021;14:3609–3618. doi:10.2147/IDR.S327652
   PubMed Web of Science ®Google Scholar
• Ayenew Z, Tigabu E, Syoum E, Ebrahim S, Assefa D, Tsige E. Multidrug resistance pattern of Acinetobacter species isolated from clinical specimens referred to the Ethiopian Public health institute: 2014 to 2018 trend analysis. PLoS One. 2021;16(4):e0250896. doi:10.1371/journal.pone.0250896
   PubMed Web of Science ®Google Scholar
• Kindu M, Derseh L, Gelaw B, Moges F. Carbapenemase-producing non-glucose-fermenting gram-negative Bacilli in Africa, Pseudomonas aeruginosa and Acinetobacter baumannii: a systematic review and meta-analysis. Int J Microbiol. 2020;2020:9461901. doi:10.1155/2020/9461901
   PubMed Web of Science ®Google Scholar
• Solomon FB, Wadilo F, Tufa EG, Mitiku M. Extended spectrum and metalo beta-lactamase producing airborne Pseudomonas aeruginosa and Acinetobacter baumanii in restricted settings of a referral hospital: a neglected condition. Antimicrob Resist Infect Control. 2017;6:106. doi:10.1186/s13756-017-0266-0
   PubMed Web of Science ®Google Scholar
• Alvarez-Otero J, Lamas-Ferreiro JL, Gonzalez-Gonzalez L, et al. Resistencia a carbapenemas en Pseudomonas aeruginosa aisladas en urocultivos: prevalencia y factores de riesgo [Carbapenem resistance in Pseudomonas aeruginosa isolated from urine cultures: prevalence and risk factors]. Rev Esp Quimioter. 2017;30(3):183–194. Spanish.
   PubMedGoogle Scholar
• Ibrahim ME. Prevalence of Acinetobacter baumannii in Saudi Arabia: risk factors, antimicrobial resistance patterns and mechanisms of carbapenem resistance. Ann Clin Microbiol Antimicrob. 2019;18(1):1. doi:10.1186/s12941-018-0301-x
   PubMed Web of Science ®Google Scholar
• Mody L, Gibson KE, Horcher A, et al. Prevalence of and risk factors for multidrug-resistant Acinetobacter baumannii colonization among high-risk nursing home residents. Infect Control Hosp Epidemiol. 2015;36(10):1155–1162. doi:10.1017/ice.2015.143
   PubMed Web of Science ®Google Scholar
• Anane AY, Apalata T, Vasaikar S, Okuthe GE, Songca S. Prevalence and molecular analysis of multidrug-resistant Acinetobacter baumannii in the extra-hospital environment in Mthatha, South Africa. Braz J Infect Dis. 2019;23(6):371–380. doi:10.1016/j.bjid.2019.09.004
   PubMed Web of Science ®Google Scholar
• Ayobami O, Willrich N, Harder T, Okeke IN, Eckmanns T, Markwart R. The incidence and prevalence of hospital-acquired (carbapenem-resistant) Acinetobacter baumannii in Europe, Eastern Mediterranean and Africa: a systematic review and meta-analysis. Emerg Microbes Infect. 2019;8(1):1747–1759. doi:10.1080/22221751.2019.1698273
   PubMedGoogle Scholar
• Lowings M, Ehlers MM, Dreyer AW, Kock MM. High prevalence of oxacillinases in clinical multidrug-resistant Acinetobacter baumannii isolates from the Tshwane region, South Africa - an update. BMC Infect Dis. 2015;15:521. doi:10.1186/s12879-015-1246-8
   PubMed Web of Science ®Google Scholar
• Aly MM, Abu Alsoud NM, Elrobh MS, Al Johani SM, Balkhy HH. High prevalence of the PER-1 gene among carbapenem-resistant Acinetobacter baumannii in Riyadh, Saudi Arabia. Eur J Clin Microbiol Infect Dis. 2016;35(11):1759–1766. doi:10.1007/s10096-016-2723-8
   PubMed Web of Science ®Google Scholar
• Dawadi P, Khadka C, Shyaula M, et al. Prevalence of metallo-beta-lactamases as a correlate of multidrug resistance among clinical Pseudomonas aeruginosa isolates in Nepal. Sci Total Environ. 2022;850:157975. doi:10.1016/j.scitotenv.2022.157975
   PubMed Web of Science ®Google Scholar
• Hu Y, Qing Y, Chen J, et al. Prevalence, risk factors, and molecular epidemiology of intestinal carbapenem-resistant Pseudomonas aeruginosa. Microbiol Spectr. 2021;9(3):e0134421. doi:10.1128/Spectrum.01344-21
   PubMed Web of Science ®Google Scholar
• Shi Q, Huang C, Xiao T, Wu Z, Xiao Y. A retrospective analysis of Pseudomonas aeruginosa bloodstream infections: prevalence, risk factors, and outcome in carbapenem-susceptible and -non-susceptible infections. Antimicrob Resist Infect Control. 2019;8:68. doi:10.1186/s13756-019-0520-8
   PubMed Web of Science ®Google Scholar